Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1985-7-2
|
pubmed:abstractText |
Adrenal catecholamines and their synthesizing enzymes were monitored during morphine treatment and after naloxone-precipitated morphine withdrawal in the rat. At 2 and 6 hr of withdrawal epinephrine content was reduced to approximately 50 and 45% of control. Five days after withdrawal a significant overshoot in adrenal epinephrine concentration was observed. Morphine treatment increased adrenal tyrosine hydroxylase activity to 160% of control. Precipitation of withdrawal with naloxone further increased adrenal tyrosine hydroxylase activity to 240% of control after 1 day; the enzyme activity returned to control values at day 7. Similar effects, but of lesser magnitude, were observed with locus ceruleus tyrosine hydroxylase activity. No increase in adrenal dopamine-beta-hydroxylase activity was seen until day 3 of withdrawal and this activity peaked at 5 days to 160% of control values. Adrenal phenylethanolamine-N-methyltransferase activity was unchanged during the time course studied. Splanchnicotomy caused depletion of adrenal epinephrine to 60% of control. Morphine withdrawal in these animals caused a further (23%) decrease in epinephrine content. These data show that epinephrine is selectively released from the adrenal medulla during naloxone-precipitated morphine withdrawal in the rat and that this release has both a direct and a centrally mediated component. The possible mechanisms underlying these biochemical changes are discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Catecholamines,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine beta-Hydroxylase,
http://linkedlifedata.com/resource/pubmed/chemical/Morphine,
http://linkedlifedata.com/resource/pubmed/chemical/Naloxone,
http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine 3-Monooxygenase
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-3565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
233
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
333-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2860239-Adrenal Medulla,
pubmed-meshheading:2860239-Animals,
pubmed-meshheading:2860239-Catecholamines,
pubmed-meshheading:2860239-Dopamine beta-Hydroxylase,
pubmed-meshheading:2860239-Dose-Response Relationship, Drug,
pubmed-meshheading:2860239-Humans,
pubmed-meshheading:2860239-Locus Coeruleus,
pubmed-meshheading:2860239-Male,
pubmed-meshheading:2860239-Morphine,
pubmed-meshheading:2860239-Naloxone,
pubmed-meshheading:2860239-Rats,
pubmed-meshheading:2860239-Rats, Inbred Strains,
pubmed-meshheading:2860239-Substance Withdrawal Syndrome,
pubmed-meshheading:2860239-Tyrosine 3-Monooxygenase
|
pubmed:year |
1985
|
pubmed:articleTitle |
Biochemical correlates of morphine withdrawal. 1. Characterization in the adrenal medulla and locus ceruleus.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|